title: The Vioxx debacle revisited.
authors.forename: Chester B
authors.initials: CB
authors.lastname: Good
authors.forename: Catherine L
authors.initials: CL
authors.lastname: Kelley
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004363:Drug Utilization; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D010818:Practice Patterns, Physicians'; D011358:Product Surveillance, Postmarketing; D012941:Social Responsibility; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib